Figure 3
Effects of luteolin administration on the expressions of cMet, Akt, ERK, MMP9 and Ki-67 in PDTX models of gastric cancer. H&E staining and immunohistochemistry were undertaken after administration for 30 days of either luteolin or DMSO (as a vehicle control). Immunodetectable protein is indicated by brown staining; nuclei are counterstained blue. Original magnification, ×200.